| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 74.8304 | 70 |
| GSM780708 | Untreated after 4 days (C2_1) | 57.947 | 63 |
| GSM780709 | Untreated after 4 days (C3_1) | 64.18 | 67 |
| GSM780719 | Untreated after 4 days (C1_2) | 62.9407 | 66 |
| GSM780720 | Untreated after 4 days (C2_2) | 70.7313 | 69 |
| GSM780721 | Untreated after 4 days (C3_2) | 63.8821 | 67 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 63.8728 | 67 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 63.468 | 66 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 62.5741 | 66 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 57.3908 | 62 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 66.0946 | 68 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 65.068 | 67 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 79.5263 | 72 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 60.1676 | 65 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 74.0848 | 70 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 84.3115 | 73 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 63.1563 | 66 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 67.4989 | 68 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 65.4555 | 67 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 64.9768 | 67 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 66.4357 | 68 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 62.1925 | 66 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 64.8013 | 67 |